Evaluation of Cerebrospinal Fluid Tau/Beta-Amyloid(42) Ratio as Diagnostic Markers for Alzheimer Disease

Publisher： Karger

E-ISSN： 1421-9913|62|6|349-355

ISSN： 0014-3022

Source： European Neurology, Vol.62, Iss.6, 2009-09, pp. : 349-355

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Brain Metabolic Correlates of Cerebrospinal Fluid Beta-Amyloid 42 and Tau in Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 27, Iss. 5, 2009-05 ,pp. : 474-480

Karger

Access to resources Recommend Favorite

Concentrations of Metals, β-Amyloid and Tau-Markers in Cerebrospinal Fluid in Patients with Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 28, Iss. 1, 2009-08 ,pp. : 88-94

Karger

Access to resources Recommend Favorite

Evaluation of the Cerebrospinal Fluid Amyloid-β1-42/Amyloid-β1-40 Ratio Measured by Alpha-LISA to Distinguish Alzheimer's Disease from Other Dementia Disorders

By  

Dementia and Geriatric Cognitive Disorders, Vol. 36, Iss. 1-2, 2013-07 ,pp. : 99-110

Karger

Access to resources Recommend Favorite

Cerebrospinal Fluid Phospho-Tau, Total Tau and β-Amyloid1–42 in the Differentiation between Alzheimer’s Disease and Vascular Dementia

By  

Dementia and Geriatric Cognitive Disorders, Vol. 14, Iss. 4, 2002-11 ,pp. : 183-190

Karger

Access to resources Recommend Favorite

The Cerebrospinal Fluid Levels of Tau, Growth-Associated Protein-43 and Soluble Amyloid Precursor Protein Correlate in Alzheimer’s Disease, Reflecting a Common Pathophysiological Process

By  

Dementia and Geriatric Cognitive Disorders, Vol. 12, Iss. 4, 2001-05 ,pp. : 257-264

Karger

Access to resources Recommend Favorite